The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases

摘要

Disclosed is a use of an active ingredient consisting of a compound of formula (IC) in free form or in the form of a pharmaceutically acceptable acid addition salt, for the manufacture of a medicament for modulating hyperlipidemia.